As one of the 23 million Americans diagnosed with cardiovascular disease, I have been adversely impacted and frustrated by my insurers’ attempts to reject the treatment plan designed my doctors. Following years of failed treatments and ineffective medications, my cardiologist suggested a new, but more expensive medication known as a PCSK9 inhibitor.
While I began taking a sample, my doctor contacted my insurer to get the necessary approval. My health insurer denied my claim on three separate occasions, delaying my treatment for at least six months. My cardiologist warned me this could be a long road due to the higher cost, but I never imagined cost-savings would supersede my health. I began to wonder if I would get approved before a heart attack.
Read more here.